Moneycontrol PRO
Open App
Upcoming Event : Traders Conclave 2022 | India's Largest Retail Stock Investors & Traders Residential Conclave

Hold Sun Pharmaceutical Industries target of Rs 510: Sharekhan

Sharekhan recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 510 in its research report dated May 27, 2020.

May 28, 2020 / 04:35 PM IST
  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Sun Pharmaceutical Industries

Sun Pharma reported healthy results for Q4FY2020; however numbers missed estimates. Sun Pharmaceutical industries (Sun Pharma) is witnessing sustained competitive pressures in the US generic business, which are unlikely to abate in the near to medium term. Also the momentum for the specialty business is likely to slow down in the near term due to covid impact. Domestic formulations, could also witness a slowdown in the current quarter on the back of Covid related issues which could impact the demand due to lower prescriptions written and advance stocking of chronic medicines.


Given persistent uncertainties in US business and India business in the near-medium term, we hold back from taking a constructive view and retain a Hold recommendation on the stock with a revised PT of Rs 510.
Read More


For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: May 28, 2020 04:35 pm
ISO 27001 - BSI Assurance Mark